IGC Pharma Inc. (IGC)
IGC trades on NYSE in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.2650
-3.99% on the day
Market cap
$27.4M
Nano cap
Revenue · 2024
$1.3M
-5.5% on 2023
Net income · 2024
-$7.1M
-560.3% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2024.
Profile
| Field | Value |
|---|---|
| Ticker | IGC on NYSE |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001326205 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | MD |
Financials · 2024
| Line | Value |
|---|---|
| Revenue | $1.3M |
| Net income | -$7.1M |
| Operating income | -$7.4M |
| Net margin | -560.3% |
| Operating margin | -585.8% |
| Revenue growth | -5.5% |
| Cash | $470K |
| Total assets | $9.1M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 21.6× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document FORM 424B5 | 424B5 | 2026-01-06 |
| Latest annual report FORM 10-KT | 10-KT | 2026-03-18 |
| Latest quarterly / interim FORM 10-Q | 10-Q | 2026-08-14 |
| Latest current report FORM 8-K | 8-K | 2026-07-14 |
| Latest proxy FORM DEFA14A | DEFA14A | 2025-08-19 |
Source: SEC EDGAR submissions feed, 815 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| MIRA | MIRA Pharmaceuticals Inc. | $0.6664 | -5.53% | $28.0M |
| RNAZ | TransCode Therapeutics Inc. | $1.68 | +3.07% | $28.4M |
| IMMP | Immutep Limited | $3.57 | -2.73% | $26.3M |
| ABVC | ABVC BioPharma Inc. | $0.9790 | -0.08% | $26.1M |
| NXTC | NextCure Inc. | $6.28 | -5.42% | $28.7M |
| ATOS | Atossa Therapeutics Inc. | $2.56 | +7.17% | $25.5M |
| MCRB | Seres Therapeutics Inc. | $2.53 | -5.60% | $25.4M |
| CNTX | Context Therapeutics Inc. | $0.2750 | -9.84% | $25.3M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier